Načítá se...
Health Canada's Proposal to Accelerate New Drug Reviews
Health Canada is proposing to update its accelerated review pathways to get important new drugs into the market more quickly. To date, the two pathways that Health Canada uses have not demonstrated that they can identify therapeutically valuable new drugs. Drugs approved under the two pathways also...
Uloženo v:
| Vydáno v: | Healthc Policy |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Longwoods Publishing
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294445/ https://ncbi.nlm.nih.gov/pubmed/32538346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12927/hcpol.2020.26227 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|